Jean Jacques Mention

Corporate Officer/Principal at OSE IMMUNOTHERAPEUTICS

Health Technology

Profile

Jean Jacques Mention is currently the Chief Business Officer at OSE Immunotherapeutics SA. Prior to this, he held positions as Director of Business Development at Axenis SAS and Head of Business Development at genOway SA.

Jean Jacques Mention active positions

Companies	Position	Start
OSE IMMUNOTHERAPEUTICS	Corporate Officer/Principal	-

All active positions of Jean Jacques Mention

Former positions of Jean Jacques Mention

Companies	Position	End
GENOWAY	Corporate Officer/Principal	-
Axenis SAS Axenis SAS BiotechnologyHealth Technology Part of genOway SA, Axenis SAS develops gene technology and products. The private company is based in Paris, France. Axenis was acquired by genOway SA on September 04, 2018 for $0.23 million.	Corporate Officer/Principal	-

See the detail of Jean Jacques Mention's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jean Jacques Mention's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
GENOWAY	Health Technology
OSE IMMUNOTHERAPEUTICS	Health Technology

Private companies	1
Axenis SAS Axenis SAS BiotechnologyHealth Technology Part of genOway SA, Axenis SAS develops gene technology and products. The private company is based in Paris, France. Axenis was acquired by genOway SA on September 04, 2018 for $0.23 million.	Health Technology

See company connections